Page 716 - Cote clinical veterinary advisor dogs and cats 4th
P. 716

Feline Lower Urinary Tract Signs, Idiopathic   333


               even before laboratory values for serum   Locate these resources in quiet places   problem, and recurrent episodes of
                        +
                                                  where the cat is not startled during use.
               potassium (K ) return if arrhythmias are   ○   Provide opportunities for the cat to hide   urolithiasis and LUTS still can occur.
  VetBooks.ir  ○   Consider decompressing the bladder by   safely and explore its environment. Placing   Nutrition/Diet  Diseases and   Disorders
               present (p. 495).
               cystocentesis before attempting to pass a
                                                  perches at windows so the cat can look
                                                                                  •  Dietary therapy may be indicated if uroliths
               urinary (urethral) catheter (p. 1009).
             ○   Several methods are described for urethral   outside and structures the cat can climb   or crystals are identified and depends on the
                                                                                    type of urolith.
                                                  on seem to be important parts of EE.
               obstruction relief. A widely used technique   ○   Safe outdoor spaces (e.g., fenced enclo-  •  Glycosaminoglycan (GAG) supplementation
               is detailed on p. 1009.            sures) provide excellent EE opportunities.  has been suggested, but its efficacy remains
             ○   Manage cats medically unless recurrent   ○   Provide a  regularly scheduled time for   unproved in cats.
               obstructions occur. For most, analgesics   petting, play, and/or trick teaching, working
               and appropriate fluid therapy are indicated.   toward at least 10 minutes each day.  Possible Complications
               Evidence is lacking for alpha-blocking   ○   Identify and resolve intercat conflict to   •  When  introducing  EE,  offer  changes  to
               drugs (e.g., phenoxybenzamine, prazosin).  the extent possible.      the cat (e.g., new food in a separate bowl
             ○   Monitor urine output frequently in very   ○   If ineffective, proceed to step 2.  rather  than in  place  of the  familiar  diet)
               ill cats. Postobstructive diuresis (>2 mL/  •  Step 2: step 1 plus consider use of phero-  to avoid precipitating a threat response.
               kg/h) may occur shortly after relief of   mones (Feliway). If ineffective, proceed to   Make changes the client wants to make,
               obstruction and rehydration. During this   step 3.                   if  possible,  to  secure  support  and  adher-
               period, it is essential to give sufficient IV   •  Step 3: steps 1 and 2 plus consider use of a   ence to the EE effort. Make changes
               fluids to replace the volume lost as urine.   tricyclic antidepressant (TCA) agent (e.g.,   sequentially.
               The diuresis declines by 2-5 days.  clomipramine or amitriptyline) or selective   •  When TCA or SSRI drugs are being used and
           •  The role of glucocorticoids (e.g., prednisone)   serotonin  reuptake  inhibitor  (SSRI;  such   the decision is made to discontinue them,
             and nonsteroidal antiinflammatory drugs   as  fluoxetine)  at  the  lowest  effective  dose   they should be tapered slowly over at least
             (e.g., aspirin, meloxicam) remains poorly   possible. These drugs should be used only   2 weeks to avoid adverse reactions.
             defined, and none of these drugs has been   after steps 1 and 2 have been implemented
             shown to be an effective treatment for   and the cat is so severely affected he/she   Recommended Monitoring
             acute  LUTS.  Nonsteroidal  antiinflamma-  continues to have recurrences. Conclusive   Liver and kidney function should be assessed
             tory drugs are absolutely contraindicated   results regarding the efficacy of behavior-  before use of TCAs and at least annually for
             in the presence of azotemia due to the risk     modifying drugs are lacking.  young animals if therapy is extended.
             of nephrotoxicity.                •  Perineal  urethrostomy  may  be  needed  in
                                                severe recurrent obstructive cases.   PROGNOSIS & OUTCOME
           Chronic Treatment                    ○   This surgery increases the risks of bacterial
           •  Step  1:  EE/multimodal  environmental   urinary tract infections, and postoperative   Most cases of idiopathic, nonobstructive, feline
             modification (MEMO)                  strictures are a potential complication.  LUTS are self-limited, usually resolving in 5-10
             ○   Provide at least one food bowl, one water   ○   Clients should be made aware that this   days. However, recurrent episodes, including
               bowl, and one litter box per cat plus one.   surgery does not correct the underlying   urinary tract obstruction, occur with variable
                                                                                  frequency. Overall prognosis depends on the
                                                                                  cat, client, and environment:
            Drugs Commonly Used for Cats With LUTS                                •  Cat
                                                                                    ○   Genetic predisposition
            Drug*             Dosage                     Potential Side Effects     ○   Duration of the problem
                                                                                    ○   Frequency of occurrences
            Acute Analgesic                                                         ○   Number of areas and different types of
            Butorphanol (Torbugesic)  0.2-0.4 mg/kg IV, IM, SQ q 2-8h (IV: use   Sedation  surfaces soiled
                              lower end of dose range; not an ideal               •  Client
                              choice due to short duration of analgesia)            ○   Ability to identify modifiable causes
            Buprenorphine (Buprenex)  0.01-0.02 mg/kg IM, IV, or SQ q               ○   Strength of bond with affected cat
                              8-12h; 0.015 mg/kg PO or sublingual/                  ○   Willingness to pay for treatment
                              transmucosal q 8-12h (anecdotal)                      ○   Amount of time to devote to solution
            Methadone         0.1-0.3 mg/kg IM, IV q 4-6h  Sedation                 ○   Willingness to accept and use medications
            Fentanyl CRI or patch   1-5 mcg/kg/h CRI or 25 mcg/h patch  Respiratory depression, bradycardia  •  Environment
            (Duragesic)                                                             ○   Number of cats in the household
                                                                                    ○   Number of affected cats
            Bladder/Urethral Contractility
                                                                                    ○   Practicality of allowing limited outdoor
            Acepromazine (PromAce)  0.01-0.05 mg/kg SQ q 8h,    Sedation, hypotension  access
                              2.5 mg/CAT PO                                         ○   Ability to rearrange the environment
            Prazosin (Minipress)  0.5 mg/CAT PO q 12h    Hypotension
            Phenoxybenzamine   2.5 mg/CAT PO q 12h       Hypotension               PEARLS & CONSIDERATIONS
            (Dibenzyline)
                                                                                  Comments
            Bethanechol (Urecholine)  2.5-5 mg/CAT PO q 12h  Salivation, vomiting, diarrhea  EE often is sufficient to suppress clinical signs
            Chronic Analgesic/Anxiolytic                                          and should be discussed with all owners of cats
            Clomipramine (Anafranil)  0.5 mg/kg PO q 24h  Sedation, anticholinergic effects  exclusively housed indoors.
            Amitriptyline (Elavil)  5-12.5 mg/CAT PO q 12-24h  Sedation, weight gain, urine
                                                         retention; urolith formation  Prevention
            Fluoxetine hydrochloride  0.5-1 mg/kg PO q 24h  Decreased food intake  EE recommendations should be provided to
                                                                                  all owners of indoor cats, not just those with
           *These are all off-label uses.                                         a clinical problem.

                                                      www.ExpertConsult.com
   711   712   713   714   715   716   717   718   719   720   721